RecallRadar
FDA · Medical devicesClass I

Nova Biomedical Corporation medical device recall: StatStrip Glucose Hospital Meter System. Model/Catalog Number: 63685.…

LeadSoftware problems

Key facts

Agency
U.S. Food and Drug Administration (FDA)
Program
Medical devices
Classification
Class I
Status
Ongoing
Event ID
95783
Recall initiated
Nov 20, 2024
Classified by FDA
Dec 20, 2024
Posted in Enforcement Report
Jan 1, 2025
Recalling firm
Nova Biomedical Corporation
Firm location
Waltham, MA, United States
Initiated by
Voluntary: Firm initiated
Firm notified customers by
E-Mail
Products in this event
3

What to do

Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.

View the official FDA record ↗

Reason for recall

A software bug within the Gen 2 StatStrip Hospital Meter firmware leads to transmission of erroneous glucose patient test results to a healthcare institution's data management system (DMS) at healthcare sites using WiFi if a user navigates to the Review Results screen while the meter is in the process of transmitting the current glucose test result to the DMS. The risk of this software defect is erroneously high or low glucose results being documented in a patient's medical record, which may lead to incorrect treatment.

A software bug within the meter firmware leads to transmission of erroneous glucose and/or ketone patient test results to a healthcare institution's data management system (DMS) at healthcare sites using WiFi if a user navigates to the Review Results screen while the meter is in the process of transmitting the current test result to the DMS.

What the classification means

  • Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.

About this recall

The firm started this recall on Nov 20, 2024. FDA classified it 30 days later, on Dec 20, 2024. This recall event covers 3 separate products, each with its own FDA recall number. Distribution reported by FDA: Distribution US Nationwide including Puerto Rico, Germany, Italy, Israel, Switzerland, Australia, Great Britain, and the Netherlands. Nova Biomedical Corporation has 7 recalls in our records.

Recalled products (3)

  • Z-0681-2025 Class I Ongoing

    StatStrip Glucose Hospital Meter System. Model/Catalog Number: 63685. Prescription use blood glucose meter for near-patient testing.

    Codes / lots: Model No 63685. UDI-DI (01)10385480636858. Software Versions: v0.0.13.10 to v0.0.13.44

    Quantity: 2,365 units

  • Z-0682-2025 Class I Ongoing

    StatStrip Glucose Ketone Hospital Meter System. Model/Catalog Number: 63683. Prescription use blood glucose ketone meter for near-patient testing

    Codes / lots: Model No 63683. UDI-DI (01)38548063685. Software versions: v0.0.13.10 to v0.0.13.44.

    Quantity: 347 units

  • Z-0683-2025 Class I Ongoing

    StatStrip Glucose Ketone (mmol/L) Hospital Meter System. Model/Catalog Number: 63910. Prescription use blood glucose ketone meter for near-patient testing

    Codes / lots: Model No 63910. UDI-DI (01)1038548063910. Software Versions: v0.0.13.10 to v0.0.13.44.

    Quantity: 1,615 units

Source and freshness

Source
U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA device enforcement dataset
Official notice
FDA Enforcement Report, event 95783
Raw record
openFDA API (JSON)
Dataset last updated by FDA
Nov 3, 2026
Imported by RecallRadar
Nov 4, 2026

Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.

More recalls from this firm